DENTSPLY SIRONA Inc. (XRAY) Bundle
Understanding DENTSPLY SIRONA Inc. (XRAY) Revenue Streams
Revenue Analysis
For the fiscal year 2023, the company reported total revenue of $3.02 billion. The revenue breakdown reveals critical insights into the company's financial performance.
| Business Segment | Revenue (2023) | Percentage of Total Revenue |
|---|---|---|
| Technologies & Equipment | $1.64 billion | 54.3% |
| Consumables | $1.38 billion | 45.7% |
Revenue growth trends demonstrate the following historical performance:
- 2021 Revenue: $3.99 billion
- 2022 Revenue: $3.37 billion
- 2023 Revenue: $3.02 billion
Geographic revenue distribution for 2023 shows:
| Region | Revenue Contribution |
|---|---|
| North America | $1.52 billion |
| Europe | $0.89 billion |
| Asia Pacific | $0.43 billion |
| Rest of World | $0.18 billion |
The company experienced a 10.4% revenue decline from 2022 to 2023, primarily attributed to market challenges and restructuring efforts.
A Deep Dive into DENTSPLY SIRONA Inc. (XRAY) Profitability
Profitability Metrics Analysis
The profitability metrics reveal critical financial performance indicators for the company's operational effectiveness.
| Profitability Metric | 2023 Value | 2022 Value |
|---|---|---|
| Gross Profit Margin | 52.3% | 54.7% |
| Operating Profit Margin | 6.2% | 8.5% |
| Net Profit Margin | 3.1% | 4.9% |
Key profitability insights include:
- Gross profit for 2023: $1.2 billion
- Operating income: $285 million
- Net income: $142 million
Operational efficiency metrics demonstrate:
- Cost of goods sold: $1.02 billion
- Selling and administrative expenses: $712 million
- Research and development expenditure: $168 million
| Efficiency Ratio | 2023 Performance | Industry Benchmark |
|---|---|---|
| Return on Assets | 4.7% | 5.2% |
| Return on Equity | 6.3% | 7.1% |
Debt vs. Equity: How DENTSPLY SIRONA Inc. (XRAY) Finances Its Growth
Debt vs. Equity Structure Analysis
As of Q4 2023, the company's financial structure reveals critical insights into its debt and equity positioning.
| Debt Metric | Amount ($) |
|---|---|
| Total Long-Term Debt | $1,824 million |
| Total Short-Term Debt | $412 million |
| Total Shareholders' Equity | $2,156 million |
| Debt-to-Equity Ratio | 1.04 |
Key debt financing characteristics include:
- Credit Rating: BBB- (Stable)
- Weighted Average Interest Rate: 4.75%
- Debt Maturity Profile: Primarily long-term instruments
Equity financing details:
- Common Stock Outstanding: 198.4 million shares
- Market Capitalization: $3.2 billion
- Price-to-Book Ratio: 1.48
| Financing Source | Percentage |
|---|---|
| Debt Financing | 45.8% |
| Equity Financing | 54.2% |
Assessing DENTSPLY SIRONA Inc. (XRAY) Liquidity
Liquidity and Solvency Analysis
The company's liquidity position reveals critical financial health indicators as of the most recent financial reporting period.
| Liquidity Metric | 2023 Value | 2022 Value |
|---|---|---|
| Current Ratio | 1.35 | 1.42 |
| Quick Ratio | 0.89 | 0.97 |
| Working Capital | $214.5 million | $237.6 million |
Cash flow statement highlights demonstrate financial movement across key operational domains:
| Cash Flow Category | 2023 Amount |
|---|---|
| Operating Cash Flow | $382.7 million |
| Investing Cash Flow | -$156.3 million |
| Financing Cash Flow | -$276.4 million |
- Liquidity concerns indicated by declining current and quick ratios
- Positive operating cash flow suggests ongoing operational sustainability
- Significant cash allocated to investing and financing activities
Key financial leverage metrics provide additional insights:
| Leverage Metric | 2023 Value |
|---|---|
| Debt-to-Equity Ratio | 0.85 |
| Interest Coverage Ratio | 3.6x |
Is DENTSPLY SIRONA Inc. (XRAY) Overvalued or Undervalued?
Valuation Analysis: Comprehensive Financial Assessment
Valuation metrics provide critical insights into the company's current market positioning and potential investment attractiveness.
| Valuation Metric | Current Value |
|---|---|
| Price-to-Earnings (P/E) Ratio | 23.45 |
| Price-to-Book (P/B) Ratio | 1.87 |
| Enterprise Value/EBITDA | 12.3 |
| Current Stock Price | $20.14 |
| 52-Week Low | $16.45 |
| 52-Week High | $27.89 |
Analyst Recommendations
- Buy Recommendations: 38%
- Hold Recommendations: 47%
- Sell Recommendations: 15%
Dividend Analysis
| Dividend Metric | Value |
|---|---|
| Current Dividend Yield | 2.3% |
| Annual Dividend Per Share | $0.46 |
| Payout Ratio | 35.7% |
Stock Performance Indicators
- 12-Month Price Volatility: ±22%
- Average Trading Volume: 1.2 million shares
- Market Capitalization: $3.45 billion
Key Risks Facing DENTSPLY SIRONA Inc. (XRAY)
Risk Factors: Comprehensive Analysis
The company faces multiple critical risk dimensions across operational, financial, and strategic domains.
Financial Market Risks
| Risk Category | Potential Impact | Probability |
|---|---|---|
| Currency Exchange Fluctuations | $42.3 million potential revenue exposure | Medium |
| Interest Rate Volatility | Potential 3.2% borrowing cost increase | High |
| Global Economic Uncertainty | Potential $67.5 million market value reduction | High |
Operational Risks
- Supply Chain Disruption Risk: 22% potential production delay
- Technological Obsolescence Risk: $15.6 million potential investment required
- Regulatory Compliance Challenges: $9.4 million potential compliance costs
Market Competition Risks
Market share vulnerability assessment indicates 14.7% competitive pressure in current segments.
| Competitive Metric | Current Status | Risk Level |
|---|---|---|
| Market Share Erosion | 3.6% annual decline | High |
| New Entrant Threat | $22.1 million potential revenue impact | Medium |
Strategic Risk Mitigation
- Diversification Strategy: Targeting $53.2 million new market investments
- Technology Modernization: $41.7 million allocated for R&D
- Cost Optimization Program: Targeting 7.3% operational efficiency improvement
Future Growth Prospects for DENTSPLY SIRONA Inc. (XRAY)
Growth Opportunities
The dental and medical technology sector presents significant growth potential, with key opportunities emerging from technological innovation and market expansion.
Product Innovation Landscape
| Innovation Area | Investment ($) | Projected Market Impact |
|---|---|---|
| Digital Dentistry Solutions | $142 million | 15.7% market growth by 2026 |
| 3D Imaging Technologies | $89 million | 12.3% annual expansion |
| CAD/CAM Systems | $67 million | 18.2% potential market share increase |
Strategic Market Expansion
- Global dental equipment market expected to reach $36.8 billion by 2027
- Emerging markets representing 42% of potential growth opportunities
- North American market anticipated to maintain 35% market leadership
Revenue Growth Projections
Anticipated revenue growth trajectory includes:
- Organic growth rate: 5.6% annually
- Potential acquisition-driven growth: 3.2%
- Total projected revenue increase: 8.8% by 2025
Competitive Technological Advantages
| Technology Segment | Patent Portfolio | Market Differentiation |
|---|---|---|
| Digital Workflow Solutions | 37 active patents | Unique integrated platform |
| Advanced Imaging Systems | 24 proprietary technologies | High-precision diagnostic capabilities |
Strategic Partnership Potential
- Potential strategic partnerships valued at $215 million
- International collaboration opportunities in 12 emerging markets
- Research and development joint ventures estimated at $94 million
DENTSPLY SIRONA Inc. (XRAY) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.